Capricor Therapeutics (CAPR) Fair Value & DCF
Score
CAPR fair value $10.01. Price $9.53. Price is about fair value.
Worked example
Cash-flow value. Starting free cash flow is $0.07 a share. Years 1 to 5 grow at 20.00%. Years 6 to 10 fade that rate in a straight line to 3% terminal growth. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $8.03 a share.
Earnings value. Next-twelve-months earnings per share of $0.42 times 28.43 is $12.00. The peer group is Biotechnology, 13 companies worth at least $10 billion. This stock has no 10-year median P/E, so the peer median of 28.4 is kept between 8 and 30, which is 28.43.
Fair value is the average of the two, $10.01. The price is $9.53, which is 4.8% below fair value.